Business / Finance

RSS

Unique real-time drug monitoring system

Titan Enterprises assisted CRISI in the early days of development of the unique flow sensor used in the BD Intelliport™, a medication management system for manual intravenous (IV) bolus injections...

From Titan Enterprises Ltd 7 May 2015

Egalet announces business highlights, financial results for first quarter 2015

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today reported business highlights and financial results for the three months ended March 31, 2015.

7 May 2015

BD reports revenues of $2.051 billion for second fiscal quarter 2015

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $2.051 billion for the second fiscal quarter ended March 31, 2015, representing a decrease of 1.0 percent from the prior-year period, or an increase of 4.9 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 7 May 2015

Wearable cognitive assessment devices a step closer as Cambridge Cognition file new patents

The combination of bio-behavioural measures and results from touch-screen cognitive tests would be used to build up a picture of a person’s mental function...

7 May 2015

Global haemophilia therapeutics market estimated to reach $13.43 billion in 2019

Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are likely to command a premium price and fuel growth in developed markets, while heightened access to treatment and larger patient volumes due to more funding for critical care are anticipated to contribute to demand in emerging markets.

7 May 2015

LaVision BioTec announces the first International Users’ Meeting on their UltraMicroscope

LaVison BioTec, developers of advanced microscopy solutions for the life sciences, announces the dates and venue of the first international users' meeting on their UltraMicroscope light sheet microscopy products.

7 May 2015

LaVision BioTec reports on the research work of the Milan-based Iannacone Laboratory to study virus responses using intravital microscopy

LaVison BioTec, developers of advanced microscopy solutions for the life sciences, report on the research of Dr Matteo Iannacone of the San Raffaele Scientific Institute in Milan where intravital microscopy is being applied to the study of host-viruses and associated immune responses.

7 May 2015

Cleaver Scientific launch safe series DNA electrophoresis products

The 'Safe' Series of products from Cleaver Scientific have been designed to make DNA electrophoresis procedures safer, more convenient and more economical to run.

From Cleaver Scientific Ltd 6 May 2015

Medilink UK Awards - The Winners 2015

The best of the UK's Life Sciences and Healthcare Technology sector have been honoured at the 2015 Medilink UK Awards.

6 May 2015

NanoPass signs license agreement for supply of MicronJet600 device to Circassia

NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for vaccines, announced today that it has entered into a license agreement for the supply of MicronJet600, its microneedle delivery device, to Circassia Pharmaceuticals plc. (Oxford, UK), a specialty biopharmaceutical company focused on the allergy market.

6 May 2015

CCM and MD Anderson partner to improve cancer care in China, Singapore

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced today that it has signed a multi-year strategic development agreement with The University of Texas MD Anderson Cancer Center, an internationally renowned cancer research, treatment and education center.

6 May 2015

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).

6 May 2015

Juniper's total revenues increase 19% to $8.3 million in first quarter 2015

Juniper Pharmaceuticals, Inc., today announced financial results for the three-month period ended March 31, 2015.

6 May 2015

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Cipher Pharmaceuticals Inc. today announced it has strengthened its Canadian dermatology portfolio by acquiring the Canadian rights to Vaniqa and Actikerall from Almirall S. A., a Spanish pharmaceutical company. Both products have been approved by Health Canada.

6 May 2015

Partners congratulate researchers on forming new biotechnology company

The Children's Hospital of Eastern Ontario, The Ottawa Hospital, the University of Ottawa and McMaster University congratulate its researchers on forming Turnstone Biologics Inc., a biotechnology company focused on developing new treatments for cancer that harness the patient's own immune system.

6 May 2015

Transition Therapeutics acquires worldwide rights from Lilly to develop, commercialize TT701

Transition Therapeutics Inc. today announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate ("TT701") from Eli Lilly and Company.

6 May 2015

Deben reports on the work of the Microscopy & Histology Core Facility at the University of Aberdeen

Deben reports on the work of the Microscopy & Histology Core Facility at the University of Aberdeen where a newly installed TEM and camera system have enhanced the services provided to users.

5 May 2015

Lucideon and European partners awarded €3.9m to train industry PhD researchers to develop drug-free antibacterial materials

Lucideon, the materials technology company, together with 9 European consortium partners, has been awarded €3.9m (£2.8m) grant by the European Commission to train industry PhD researchers for the development of drug-free antibacterial materials used for medical applications, such as wound care and implants.

From Lucideon 5 May 2015

CMC Biologics to supply bulk drug substance for Emergent BioSolutions' IXINITY

CMC Biologics, Inc., a global CMO dedicated to process development and production of biopharmaceuticals for clinical and commercial use, today announced that it will supply bulk drug substance for Emergent BioSolutions' recently FDA-approved product, IXINITY® [coagulation factor IX (recombinant)].

5 May 2015

Bio-Techne's net sales increase 19% to $114.2 million in third quarter 2015

Bio-Techne Corporation today reported its financial results for the third quarter ended March 31, 2015.

From ProteinSimple 5 May 2015

Business / Finance

Unique real-time drug monitoring system

Egalet announces business highlights, financial results for first quarter 2015

BD reports revenues of $2.051 billion for second fiscal quarter 2015

Wearable cognitive assessment devices a step closer as Cambridge Cognition file new patents

Global haemophilia therapeutics market estimated to reach $13.43 billion in 2019

LaVision BioTec announces the first International Users’ Meeting on their UltraMicroscope

LaVision BioTec reports on the research work of the Milan-based Iannacone Laboratory to study virus responses using intravital microscopy

Cleaver Scientific launch safe series DNA electrophoresis products

Medilink UK Awards - The Winners 2015

NanoPass signs license agreement for supply of MicronJet600 device to Circassia

CCM and MD Anderson partner to improve cancer care in China, Singapore

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Juniper's total revenues increase 19% to $8.3 million in first quarter 2015

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Partners congratulate researchers on forming new biotechnology company

Transition Therapeutics acquires worldwide rights from Lilly to develop, commercialize TT701

Deben reports on the work of the Microscopy & Histology Core Facility at the University of Aberdeen

Lucideon and European partners awarded €3.9m to train industry PhD researchers to develop drug-free antibacterial materials

CMC Biologics to supply bulk drug substance for Emergent BioSolutions' IXINITY

Bio-Techne's net sales increase 19% to $114.2 million in third quarter 2015

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News